264 related articles for article (PubMed ID: 18839752)
1. The public funding of expensive cancer therapies: synthesizing the "3Es"--evidence, economics, and ethics.
Kirby J; Somers E; Simpson C; McPhee J
Organ Ethic; 2008; 4(2):97-108. PubMed ID: 18839752
[TBL] [Abstract][Full Text] [Related]
2. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
3. European perspective on the costs and cost-effectiveness of cancer therapies.
Drummond MF; Mason AR
J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
[TBL] [Abstract][Full Text] [Related]
4. Core and comprehensive health care services: 1. Introduction to the Canadian Medical Association's decision-making framework.
Wilson R; Rowan MS; Henderson J
CMAJ; 1995 Apr; 152(7):1063-6. PubMed ID: 7712418
[TBL] [Abstract][Full Text] [Related]
5. Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.
Evans WK; Nefsky M; Pater J; Browman G; Cowan DH
Chronic Dis Can; 2002; 23(4):152-6. PubMed ID: 12517323
[TBL] [Abstract][Full Text] [Related]
6. Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing.
Simpson CS; Hoffmaster B; Dorian P
Can J Cardiol; 2005 May; 21(7):595-9. PubMed ID: 15940358
[TBL] [Abstract][Full Text] [Related]
7. Public healthcare resource allocation and the Rule of Rescue.
Cookson R; McCabe C; Tsuchiya A
J Med Ethics; 2008 Jul; 34(7):540-4. PubMed ID: 18591290
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
Lopert R
Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
[TBL] [Abstract][Full Text] [Related]
9. Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding.
Sinclair S; Hagen NA; Chambers C; Manns B; Simon A; Browman GP
Health Policy; 2008 May; 86(2-3):381-90. PubMed ID: 18243395
[TBL] [Abstract][Full Text] [Related]
10. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
11. Priority setting and the ethics of resource allocation within VA healthcare facilities: results of a survey.
Foglia MB; Pearlman RA; Bottrell MM; Altemose JA; Fox E
Organ Ethic; 2008; 4(2):83-96. PubMed ID: 18839751
[TBL] [Abstract][Full Text] [Related]
12. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: evidence-based approach and consensus decision-making.
Al Awaidy S
Vaccine; 2010 Apr; 28 Suppl 1():A39-41. PubMed ID: 20412995
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
14. Role of health technology assessment in shaping the benefits package in The Netherlands.
Stolk EA; de Bont A; van Halteren AR; Bijlmer RJ; Poley MJ
Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):85-94. PubMed ID: 19371181
[TBL] [Abstract][Full Text] [Related]
15. Redefining comprehensiveness in the deficit era.
Sawyer DM; Williams JR
Hum Health Care Int; 1996 Apr; 12(2):E8. PubMed ID: 14986600
[TBL] [Abstract][Full Text] [Related]
16. The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy.
Roughead EE; Gilbert AL; Vitry AI
Health Policy; 2008 Dec; 88(2-3):250-7. PubMed ID: 18468714
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of cancer therapy from the perspective of a statutory health insurance].
Rebscher H; Schellhammer S; Kopp T; Scharnetzky E
Urologe A; 2011 Dec; 50(12):1584-90. PubMed ID: 22159704
[TBL] [Abstract][Full Text] [Related]
18. Attitudes towards priority-setting and rationing in healthcare -- an exploratory survey of Swedish medical students.
Omar F; Tinghög G; Tinghög P; Carlsson P
Scand J Public Health; 2009 Mar; 37(2):122-30. PubMed ID: 19141543
[TBL] [Abstract][Full Text] [Related]
19. Inequalities and healthcare reform in Chile: equity of what?
Burrows J
J Med Ethics; 2008 Sep; 34(9):e13. PubMed ID: 18757613
[TBL] [Abstract][Full Text] [Related]
20. Healthcare reform through rationing.
Floyd EJ
J Healthc Manag; 2003; 48(4):233-41. PubMed ID: 12908223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
